Fatal Anaphylactic Shock Ceftriaxone-Induced in a 4-Year-Old Child

Gioacchino Calapai1, Selene Imbesi, Elvira Ventura-Spagnolo

  • 1From the *Department of Clinical and Experimental Medicine, Section of Pharmacology; †Department of Clinical and Experimental Medicine, School and Unit of Allergy and Clinical Immunology, University of Messina, Messina; ‡Department of Biotechnology and Legal Medicine, Section of Legal Medicine, University of Palermo, Palermo; §Department of Drug Sciences and Health Products, University of Messina; ∥IRCCS Centro Neurolesi "Bonino-Pulejo", Messina; and ¶Institute of Biomedicine and MolecularImmunology "A. Monroy" (IBIM)-Consiglio Nazionale delle Ricerche (CNR), Palermo, Italy.

Pediatric Emergency Care
|December 17, 2014
PubMed

Insights

Ceftriaxone, a common cephalosporin antibiotic, can rarely cause fatal anaphylaxis. This case highlights a fatal reaction in a child despite prior tolerance, emphasizing the risk of severe allergic reactions.

Area of Science:

  • Pharmacology
  • Immunology
  • Pediatrics

Background:

  • Ceftriaxone is a widely utilized cephalosporin antibiotic in clinical settings.
  • Anaphylaxis following ceftriaxone administration is documented as a rare occurrence.

Observation:

  • This report details a fatal case of anaphylactic shock in a pediatric patient after receiving ceftriaxone.
  • The child had a history of tolerating ceftriaxone during previous exposures.

Findings:

  • Clinical data suggests allergic pathogenesis, including rapid symptom onset post-administration and prior exposure indicating potential sensitization.
  • Postmortem examination revealed polivisceral congestion and significant eosinophilia in histological analyses, supporting the allergic reaction.

Implications:

  • This case underscores the potential for severe, life-threatening allergic reactions to ceftriaxone, even in patients with a history of tolerance.
  • Healthcare providers should remain vigilant for rare but severe adverse drug reactions, particularly anaphylaxis, associated with commonly used antibiotics like ceftriaxone.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
34.4K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
238
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
182
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
149
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
251